Cytokinetics, Incorporated — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-7K
Book Value Per Share
$-5K
Free Cash Flow Per Share
$-4K
Cash Per Share
$1K
Revenue Per Share
$733
OCF Per Share
$-4K
Return on Equity
197.5%
Return on Assets
-55.5%
Return on Invested Capital
212.4%
Debt to Equity
-0.37
Current Ratio
4.53
Quick Ratio
4.53
Asset Turnover
0.06
Days Sales Outstanding
73.65
R&D / Revenue
472.5%
SBC / Revenue
127.5%
Capex / Revenue
28.2%
Working Capital
$715M
Net Current Asset Value
$-1.17B
Invested Capital
$-413M
OCF / Net Income
0.65
FCF / Net Income
0.68
Accruals Ratio (Sloan)
-19.3%
Net Debt
$124M
Net Debt / EBITDA
-0.21
Interest Coverage
-13.43
Cash Coverage
-11.19
Capex Coverage
-20.56
Tangible Common Equity
$-660M
TCE / Total Assets
-46.3%
NOPAT
$-484M
Cash ROIC
234.9%
WC / Revenue
811.6%
Capex / D&A
2.45
Reinvestment Rate
-2.4%
Total Payout Ratio
—
Asset Growth vs Revenue Growth
-374.9%
Revenue 5Y CAGR
9.5%
Book Value 5Y CAGR
—
Stock Price (FY-end)
$64
Market Cap
$8M
P/E Ratio
—
P/S Ratio
0.09
P/B Ratio
—
P/TB Ratio
—
P/OCF Ratio
—
P/FCF Ratio
—
Enterprise Value
$131M
EV / EBITDA
—
EV / Sales
1.49
EV / FCF
—
FCF Yield
-7008.1%
Shareholder Yield
-1471.4%
R&D Yield
5451.5%
Capex Yield
325.1%
Operating Leverage
—
Graham Number
—
Shares Variation (YoY)
7.3%
Beta (5Y)
1.02
Cost of Equity
9.6%
Cost of Debt (after tax)
14.6%
WACC
14.5%
ROIC - WACC Spread
198.0%
52W High
$68
52W Low
$30
Trailing Return 1Y
34.2%
Trailing Return 5Y
202.9%
F-Score (Piotroski)
2.00
Z-Score (Altman)
-4.18
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.